Reuters logo
BRIEF-ELSALYS BIOTECH ACQUIRES FROM JAZZ PHARMA WORLDWIDE RIGHTS OF LEUKOTAC
October 12, 2017 / 4:10 PM / 2 months ago

BRIEF-ELSALYS BIOTECH ACQUIRES FROM JAZZ PHARMA WORLDWIDE RIGHTS OF LEUKOTAC

Oct 12 (Reuters) - Elsalys Biotech:

* ELSALYS BIOTECH ACQUIRES FROM JAZZ PHARMACEUTICALS THE WORLDWIDE RIGHTS OF LEUKOTAC

* ‍ELSALYS BIOTECH SAYS HAS INITIATED DISCUSSION WITH EUROPEAN HEALTH AUTHORITIES AND WILL ENGAGE IN REGULATORY INTERACTIONS WITH FDA IN 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below